Medial temporal lobe neuronal damage in temporal and extratemporal lesional epilepsy

Neurology

Volumn 54, Issue 7, 2000, Pages 1465-1470

  Miller, S P ^a   Li, L M ^a   Cendes, F ^a   Tasch, E ^a   Andermann, F ^a   Dubeau, F ^a   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Epilepsy; MRS; Temporal lobe

Indexed keywords

N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NERVE INJURY; PATHOGENESIS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; SCHOOL CHILD; TEMPORAL LOBE EPILEPSY;

EID: 0034636185     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.7.1465     Document Type: Article

References (27)

1. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32:429-445.
2. Manford M, Hart YM, Sander JWAS, Shorvon SD. National General Practice Study of Epilepsy (NGPSE): partial seizure patterns in a general population. Neurology 1992;34:1911-1917.
3. Cendes F, Cook MJ, Watson C, et al. Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology 1995;45:2058-2064.
4. Gadian DG. N-acetylaspartate and epilepsy. Magn Reson Imaging 1995;13:1193-1195.
5. Cross JH, Connelly A, Jackson GD, Johnson CL, Neville BG, Gadian DG. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann Neurol 1996;39:107-113.
6. Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology 1994;193:465-472.
7. Hetherington H, Kuzniecky R, Pan J, et al. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol 1995;38:396-404.
8. Garcia PA, Laxer KD, Ng T. Application of spectroscopic imaging in epilepsy. Magn Reson Imaging 1995;13:1181-1185.
9. Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Proton MR spectroscopic imaging and MRI volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 1997;42:737-746.
10. Kuzniecky R, Hugg JW, Hetherington H, et al. Relative utility of H-1 spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 1998;51:66-71.
11. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994;44:1411-1417.
12. Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997;202:809-817.
13. Stanley JA, Cendes F, Dubeau F, Andermann F, Arnold DL. Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy. Epilepsia 1998;39:267-273.
14. Li LM, Cendes F, Bastos AC, Andermann F, Dubeau F, Arnold DL. Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton MR spectroscopic imaging study. Neurology 1998;50:755-759.
15. Kuzniecky R, Hetherington H, Pan J, et al. Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology 1997;48:1018-1024.
16. Roth K, Kimber BJ, Feeney J. Data shift accumulation and alternate delay accumulation techniques for overcoming dynamic range problems. J Magn Reson 1980;41:302-309.
17. Petroff OA, Pleban LA, Spencer DD. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995;13:1197-1211.
18. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 1997;49:1525-1533.
19. Glaser GH. Treatment of intractable temporal lobe-limbic epilepsy (complex partial seizures) by temporal lobectomy. Ann Neurol 1980;8:455-459.
20. Li LM, Cendes F, Andermann F, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain 1999;122: 799-805.
21. Levesque MF, Nakasato N, Vinters HV, Babb TL. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg 1991; 75:364-370.
22. Li LM, Fish DR, Sisodiya SM, Shorvon SD, Alsanjari N, Stevens JM. High resolution magnetic resonance imaging in adults with partial or secondary generalized epilepsy attending a tertiary referral unit. J Neurol Neurosurg Psychiatry 1995;59:384-387.
23. Li LM, Cendes F, Watson C, et al. Surgical treatment of patients with single and dual pathology: relevance of lesion and hippocampal atrophy to seizure outcome. Neurology 1997; 48:437-444.
24. Cascino GD, Jack CR Jr, Sharbrough FW, Kelly PJ, Marsh WR. MRI assessments of hippocampal pathology in extratemporal lesional epilepsy. Neurology 1993;43:2380-2382.
25. Raymond AA, Fish DR, Stevens JM, Cook MJ, Sisodya SM, Shorvon SD. Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology 1994;44: 1841-1845.
26. Tasch E, Cendes F, Li LM, Dubeau F, Andermann F, Arnold DL. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann Neurol 1999;45:568-576.
27. Vermathen P, Ende G, Laxer KD, Knowlton RC, Matson GB, Weiner MW. Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Ann Neurol 1997; 42:194-199.